ATP2A2 Gene Acrokeratosis verruciformis Genetic Test
Test Name: ATP2A2 Gene Acrokeratosis verruciformis Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test gene ATP2A2
Test Details
The ATP2A2 gene is associated with a condition called acrokeratosis verruciformis (AKV). AKV is a rare genetic disorder characterized by the development of wart-like skin lesions on the hands and feet. These lesions can be persistent and resistant to treatment.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AKV, NGS genetic testing can be used to identify mutations or variations in the ATP2A2 gene that may be responsible for causing the condition. By analyzing the ATP2A2 gene, NGS genetic testing can help confirm a diagnosis of AKV and provide valuable information about the specific genetic changes involved. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment decisions.
It is important to note that genetic testing for AKV is typically performed by healthcare professionals with expertise in genetics. If you suspect you or someone you know may have AKV, it is recommended to consult with a healthcare provider who can assess your specific situation and guide you through the appropriate testing process.
| Test Name | ATP2A2 Gene Acrokeratosis verruciformis Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test gene ATP2A2 |
| Test Details |
The ATP2A2 gene is associated with a condition called acrokeratosis verruciformis (AKV). AKV is a rare genetic disorder characterized by the development of wart-like skin lesions on the hands and feet. These lesions can be persistent and resistant to treatment. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AKV, NGS genetic testing can be used to identify mutations or variations in the ATP2A2 gene that may be responsible for causing the condition. By analyzing the ATP2A2 gene, NGS genetic testing can help confirm a diagnosis of AKV and provide valuable information about the specific genetic changes involved. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment decisions. It is important to note that genetic testing for AKV is typically performed by healthcare professionals with expertise in genetics. If you suspect you or someone you know may have AKV, it is recommended to consult with a healthcare provider who can assess your specific situation and guide you through the appropriate testing process. |
